Brokerages Set The Joint Corp. (NASDAQ:JYNT) PT at $22.00

The Joint Corp. (NASDAQ:JYNT - Get Free Report) has been given an average recommendation of "Moderate Buy" by the four analysts that are covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $22.00.

Several equities analysts have recently issued reports on JYNT shares. Roth Mkm restated a "buy" rating and issued a $16.00 price objective (up previously from $13.00) on shares of Joint in a research report on Friday. B. Riley lifted their price objective on Joint from $12.00 to $20.00 and gave the company a "buy" rating in a report on Monday. Finally, TheStreet cut Joint from a "c-" rating to a "d" rating in a research note on Thursday, March 7th.

Joint Trading Down 2.0 %

NASDAQ:JYNT traded down $0.33 during mid-day trading on Monday, hitting $15.79. 143,009 shares of the company's stock traded hands, compared to its average volume of 90,058. The firm has a 50 day moving average of $12.17 and a two-hundred day moving average of $10.21. The firm has a market capitalization of $235.90 million, a price-to-earnings ratio of -21.05 and a beta of 1.58. Joint has a 12 month low of $7.31 and a 12 month high of $16.35.

Joint (NASDAQ:JYNT - Get Free Report) last posted its quarterly earnings results on Thursday, March 7th. The company reported $0.07 earnings per share for the quarter, topping analysts' consensus estimates of $0.03 by $0.04. The firm had revenue of $30.61 million for the quarter, compared to the consensus estimate of $29.63 million. Joint had a negative net margin of 9.24% and a positive return on equity of 3.94%. As a group, equities research analysts expect that Joint will post 0.13 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of JYNT. Hudson Bay Capital Management LP bought a new stake in Joint during the third quarter worth $867,000. WINTON GROUP Ltd purchased a new position in Joint in the third quarter worth $179,000. First Foundation Advisors bought a new position in Joint in the 3rd quarter valued at $1,336,000. Trexquant Investment LP increased its position in shares of Joint by 15.2% during the 3rd quarter. Trexquant Investment LP now owns 76,589 shares of the company's stock valued at $689,000 after purchasing an additional 10,122 shares during the last quarter. Finally, Skylands Capital LLC raised its stake in shares of Joint by 20.3% during the 4th quarter. Skylands Capital LLC now owns 603,640 shares of the company's stock worth $5,801,000 after purchasing an additional 101,850 shares during the period. Institutional investors and hedge funds own 76.88% of the company's stock.

About Joint

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.